Latest News

Protests and boycotts have driven many EV buyers to look elsewhere. Has Tesla's growth story stalled?

UK stocks fell on Wednesday as global markets braced for U.S. President Donald Trump's announcement of reciprocal tariffs.

Tesla’s market share in 15 European countries dropped to 9.3% from 17.9%.

Nonresidential construction spending rises to record levels in February.

Tesla has been a popular stock to own in recent years. Members of Congress owning the stock could have potential conflicts of interest with CEO Elon Musk now involved in the White House.

NVIDIA Corp (NASDAQ: NVDA) shares have fallen 19.6% year to date, pressured by ongoing concerns about AI spending, trade restrictions and broader market weakness. The stock, which was one of the best-performing names in 2024, has struggled in 2025 as investors reassess growth expectations and adjust to an increasingly uncertain economic environment.

This is being caused by weakness in the stock market, which is reflected in the MACD.

NICE recommended Pfizer's Adcetris for NHS use in advanced Hodgkin lymphoma, citing strong trial data and a new discount agreement with Takeda.

JP Morgan raises Sportradar's price target to $27, boosting 2026 revenue and EBITDA forecasts, driven by live betting and data innovation.

Major U.S. banks report Q1 2025 results April 11, with analysts watching loan growth, trading revenue, and policy risks.

Here are the five best-performing commodity ETFs of the first quarter of 2025.

Markets were ticking higher Wednesday after a solid private sector jobs report for the month of March, offsetting pre-market losses due to looming tariffs.

Roche's MUSETTE trial found no additional benefit of high-dose Ocrevus over the 600 mg IV dose, reaffirming its efficacy and safety for relapsing multiple sclerosis.